Information from other studies regarding CBS in AML is somewhat limited and focuses primarily on investigating the efficacy of anticancer chemotherapy in patients with increased enzyme expression, particularly due to trisomy of chromosome 21, where the gene locus is located. This evidence concerns the gene CBS and acute myeloid leukemia.